Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6387697 | 6258537 | F | 1 | 6387697-4 | 20070209 | 20090914 | 20090930 | EXP | MC200700150 | THE MEDICINES COMPANY | 60 | YR | M | N | 108 | KG | 20090924 | MD | UNITED STATES |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6387697 | 1012374666 | PS | ANGIOMAX | 1 | INTRAVENOUS BOLUS | 16 ML, BOLUS, IV BOLUS; 37 ML, HR, INTRAVENOUS | Y | D | 20873 | ||
| 6387697 | 1012429727 | SS | CANGRELOR FOR INJECTION (CANGRELOR) INJECTION | 2 | INTRAVENOUS BOLUS | 8 ML, BOLUS, IV BOLUS; 64.2 ML, HR, INTRAVENOUS | Y | D |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 6387697 | 1012374666 | PERCUTANEOUS CORONARY INTERVENTION |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 6387697 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 6387697 | CEREBROVASCULAR ACCIDENT |
| 6387697 | GINGIVAL BLEEDING |
| 6387697 | OPHTHALMOPLEGIA |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 6387697 | HP |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 6387697 | 1012374666 | 20070209 | 20070209 | ||
| 6387697 | 1012374666 | 20070209 | 20070209 | ||
| 6387697 | 1012429727 | 20070209 | 20070209 | ||
| 6387697 | 1012429727 | 20070209 | 20070209 |